These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 31412740)

  • 1. Atherosclerosis in Chronic Kidney Disease: More, Less, or Just Different?
    Valdivielso JM; Rodríguez-Puyol D; Pascual J; Barrios C; Bermúdez-López M; Sánchez-Niño MD; Pérez-Fernández M; Ortiz A
    Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):1938-1966. PubMed ID: 31412740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Subclinical Atheromatosis Progression over 2 Years in Patients with Different Stages of CKD.
    Gracia M; Betriu À; Martínez-Alonso M; Arroyo D; Abajo M; Fernández E; Valdivielso JM;
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):287-96. PubMed ID: 26668022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of subclinical atheromatosis and associated risk factors in chronic kidney disease: the NEFRONA study.
    Betriu A; Martinez-Alonso M; Arcidiacono MV; Cannata-Andia J; Pascual J; Valdivielso JM; Fernández E;
    Nephrol Dial Transplant; 2014 Jul; 29(7):1415-22. PubMed ID: 24586070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predicting cardiovascular events in chronic kidney disease patients. Role of subclinical atheromatosis extent assessed by vascular ultrasound.
    Valdivielso JM; Betriu A; Martinez-Alonso M; Arroyo D; Bermudez-Lopez M; Fernandez E;
    PLoS One; 2017; 12(10):e0186665. PubMed ID: 29045466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial Stiffness in the Heart Disease of CKD.
    Zanoli L; Lentini P; Briet M; Castellino P; House AA; London GM; Malatino L; McCullough PA; Mikhailidis DP; Boutouyrie P
    J Am Soc Nephrol; 2019 Jun; 30(6):918-928. PubMed ID: 31040188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: the NEFRONA study.
    Arroyo D; Betriu A; Valls J; Gorriz JL; Pallares V; Abajo M; Gracia M; Valdivielso JM; Fernandez E;
    Nephrol Dial Transplant; 2017 Mar; 32(3):513-520. PubMed ID: 27190385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical atherosclerosis burden predicts cardiovascular events in individuals with diabetes and chronic kidney disease.
    Palanca A; Castelblanco E; Betriu À; Perpiñán H; Soldevila B; Valdivielso JM; Bermúdez-Lopez M; Puig-Jové C; Puig-Domingo M; Groop PH; Fernández E; Alonso N; Mauricio D
    Cardiovasc Diabetol; 2019 Jul; 18(1):93. PubMed ID: 31324183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations Between Kidney Disease Measures and Regional Pulse Wave Velocity in a Large Community-Based Cohort: The Atherosclerosis Risk in Communities (ARIC) Study.
    Kim ED; Tanaka H; Ballew SH; Sang Y; Heiss G; Coresh J; Matsushita K
    Am J Kidney Dis; 2018 Nov; 72(5):682-690. PubMed ID: 30007506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of serum phosphorus with subclinical atherosclerosis in chronic kidney disease. Sex makes a difference.
    Martín M; Valls J; Betriu A; Fernández E; Valdivielso JM
    Atherosclerosis; 2015 Jul; 241(1):264-70. PubMed ID: 25748053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease in children with chronic kidney disease.
    Mitsnefes MM
    J Am Soc Nephrol; 2012 Apr; 23(4):578-85. PubMed ID: 22383696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and progression of subclinical atherosclerosis in patients with chronic kidney disease and diabetes.
    Palanca A; Castelblanco E; Perpiñán H; Betriu À; Soldevila B; Valdivielso JM; Bermúdez M; Duran X; Fernández E; Puig-Domingo M; Groop PH; Alonso N; Mauricio D
    Atherosclerosis; 2018 Sep; 276():50-57. PubMed ID: 30032025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and management of atherosclerotic cardiovascular disease in chronic kidney disease: a review.
    Mathew RO; Bangalore S; Lavelle MP; Pellikka PA; Sidhu MS; Boden WE; Asif A
    Kidney Int; 2017 Apr; 91(4):797-807. PubMed ID: 28040264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observational multicenter study to evaluate the prevalence and prognosis of subclinical atheromatosis in a Spanish chronic kidney disease cohort: baseline data from the NEFRONA study.
    Arroyo D; Betriu A; Martinez-Alonso M; Vidal T; Valdivielso JM; Fernández E;
    BMC Nephrol; 2014 Oct; 15():168. PubMed ID: 25326683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pravastatin in people with diabetes and chronic kidney disease.
    Tonelli M; Keech A; Shepherd J; Sacks F; Tonkin A; Packard C; Pfeffer M; Simes J; Isles C; Furberg C; West M; Craven T; Curhan G
    J Am Soc Nephrol; 2005 Dec; 16(12):3748-54. PubMed ID: 16251235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impacts of chronic kidney disease and diabetes on cardiovascular mortality in a general Japanese population: A 20-year follow-up of the NIPPON DATA90 study.
    Hirata A; Okamura T; Sugiyama D; Kuwabara K; Kadota A; Fujiyoshi A; Miura K; Okuda N; Ohkubo T; Okayama A; Ueshima H;
    Eur J Prev Cardiol; 2017 Mar; 24(5):505-513. PubMed ID: 27856810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excess mortality attributable to chronic kidney disease. Results from the PIRP project.
    Gibertoni D; Mandreoli M; Rucci P; Fantini MP; Rigotti A; Scarpioni R; Santoro A
    J Nephrol; 2016 Oct; 29(5):663-71. PubMed ID: 26498295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular calcification in patients with nondialysis CKD over 3 years.
    Górriz JL; Molina P; Cerverón MJ; Vila R; Bover J; Nieto J; Barril G; Martínez-Castelao A; Fernández E; Escudero V; Piñera C; Adragao T; Navarro-Gonzalez JF; Molinero LM; Castro-Alonso C; Pallardó LM; Jamal SA
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):654-66. PubMed ID: 25770175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherosclerosis in CKD: differences from the general population.
    Drüeke TB; Massy ZA
    Nat Rev Nephrol; 2010 Dec; 6(12):723-35. PubMed ID: 20978469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin Autofluorescence and Subclinical Atherosclerosis in Mild to Moderate Chronic Kidney Disease: A Case-Control Study.
    Sánchez E; Betriu À; Arroyo D; López C; Hernández M; Rius F; Fernández E; Lecube A
    PLoS One; 2017; 12(1):e0170778. PubMed ID: 28141808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcopenia and cardiovascular risk indices in patients with chronic kidney disease on conservative and replacement therapy.
    Lai S; Muscaritoli M; Andreozzi P; Sgreccia A; De Leo S; Mazzaferro S; Mitterhofer AP; Pasquali M; Protopapa P; Spagnoli A; Amabile MI; Molfino A
    Nutrition; 2019 Jun; 62():108-114. PubMed ID: 30875540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.